Seqirus GmbH
4 products tracked · names used in filings: Seqirus GmbH, Seqirus S.r.l.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Zoonotic Influenza Vaccine Seqirus zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted) | Authorised | 2023-10-09 |
| 🇪🇺 | Aflunov zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) | Authorised | 2010-11-28 |
| 🇪🇺 | Foclivia pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) | Authorised | 2009-10-18 |
| 🇪🇺 | Optaflu influenza vaccine (surface antigen, inactivated, prepared in cell cultures) | Expired | 2007-06-01 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.